Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations
Clinical trial NCT02352844 · COMPLETED
Trial details
- NCT number
- NCT02352844
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-07
- Primary completion
- 2017-08-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.